85 related articles for article (PubMed ID: 18830254)
1. MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients.
Stralen E; Leguit RJ; Begthel H; Michaux L; Buijs A; Lemmens H; Scheiff JM; Doyen C; Pierre P; Forget F; Clevers HC; Bast B
Leukemia; 2009 Apr; 23(4):801-3. PubMed ID: 18830254
[No Abstract] [Full Text] [Related]
2. The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB: a molecular and genetic analysis of the chromosomal breakpoint.
Boersma-Vreugdenhil GR; Kuipers J; Van Stralen E; Peeters T; Michaux L; Hagemeijer A; Pearson PL; Clevers HC; Bast BJ
Br J Haematol; 2004 Aug; 126(3):355-63. PubMed ID: 15257707
[TBL] [Abstract][Full Text] [Related]
3. The t(14;20)(q32;q12): a rare cytogenetic change in multiple myeloma associated with poor outcome.
Vekemans MC; Lemmens H; Delforge M; Doyen C; Pierre P; Demuynck H; Bries G; Lemmens J; Meeus P; Straetmans N; Bauwens D; Vidrequin S; Rack K; Vandenberghe P; Wlodarska I; Michaux L
Br J Haematol; 2010 Jun; 149(6):901-4. PubMed ID: 20148877
[No Abstract] [Full Text] [Related]
4. Ectopic expression of MAFB gene in human myeloma cells carrying (14;20)(q32;q11) chromosomal translocations.
Hanamura I; Iida S; Akano Y; Hayami Y; Kato M; Miura K; Harada S; Banno S; Wakita A; Kiyoi H; Naoe T; Shimizu S; Sonta SI; Nitta M; Taniwaki M; Ueda R
Jpn J Cancer Res; 2001 Jun; 92(6):638-44. PubMed ID: 11429052
[TBL] [Abstract][Full Text] [Related]
5. Immunoreactivity for cyclin D1 is a reliable marker of gene aberration in plasma cell myeloma but does not specify patients prognosis.
Pruneri G; Alietti A; Agnelli L; Morabito F; Laszlo D; Calabrese L; Fabris S; Bertolini F; Agazzi A; Bottiglieri L; Raviele PR; Baldini L; Pileri S; Sabattini E; Bosari S; Maisonneuve P; Lambertenghi-Deliliers G; Bertoni F; Martinelli G; Viale G; Neri A
Leuk Res; 2008 Oct; 32(10):1628-32. PubMed ID: 18355918
[No Abstract] [Full Text] [Related]
6. Translocation (11;14)(q13;q32) and partial trisomy 1q in a case of multiple myeloma.
Kwong YL; Lie AK; Chan LC
Am J Hematol; 1993 Nov; 44(3):212-3. PubMed ID: 8213777
[No Abstract] [Full Text] [Related]
7. [Nonsecretory myeloma with t(14;18)(q32;21) chromosome abnormality].
Fujii H; Maekawa T; Kanoh T; Ohnaka T; Kamezaki H; Nishida K; Urata Y
Rinsho Ketsueki; 1987 Apr; 28(4):601-7. PubMed ID: 3626051
[No Abstract] [Full Text] [Related]
8. The (11;14)(q13;q32) translocation in multiple myeloma. A morphologic and immunohistochemical study.
Hoyer JD; Hanson CA; Fonseca R; Greipp PR; Dewald GW; Kurtin PJ
Am J Clin Pathol; 2000 Jun; 113(6):831-7. PubMed ID: 10874884
[TBL] [Abstract][Full Text] [Related]
9. Global real-time quantitative reverse transcription-polymerase chain reaction detecting proto-oncogenes associated with 14q32 chromosomal translocation as a valuable marker for predicting survival in multiple myeloma.
Inagaki A; Tajima E; Uranishi M; Totani H; Asao Y; Ogura H; Masaki A; Yoshida T; Mori F; Ito A; Yano H; Ri M; Kayukawa S; Kataoka T; Kusumoto S; Ishida T; Hayami Y; Hanamura I; Komatsu H; Inagaki H; Matsuda Y; Ueda R; Iida S
Leuk Res; 2013 Dec; 37(12):1648-55. PubMed ID: 24210217
[TBL] [Abstract][Full Text] [Related]
10. Translocation t(4;14) retains prognostic significance even in the setting of high-risk molecular signature.
Chng WJ; Kuehl WM; Bergsagel PL; Fonseca R
Leukemia; 2008 Feb; 22(2):459-61. PubMed ID: 17805328
[No Abstract] [Full Text] [Related]
11. Detection of t(4;14)(p16.3;q32) chromosomal translocation in multiple myeloma by reverse transcription-polymerase chain reaction analysis of IGH-MMSET fusion transcripts.
Malgeri U; Baldini L; Perfetti V; Fabris S; Vignarelli MC; Colombo G; Lotti V; Compasso S; Bogni S; Lombardi L; Maiolo AT; Neri A
Cancer Res; 2000 Aug; 60(15):4058-61. PubMed ID: 10945609
[TBL] [Abstract][Full Text] [Related]
12. IgM myeloma with t(4;14)(p16;q32).
Ackroyd S; O'Connor SJ; Rawstron AC; Owen RG
Cancer Genet Cytogenet; 2005 Oct; 162(2):183-4. PubMed ID: 16213370
[No Abstract] [Full Text] [Related]
13. Identification of a novel IGH-MMSET fusion transcript in a human myeloma cell line with the t(4;14)(p16.3;q32) chromosomal translocation.
Intini D; Fabris S; Storlazzi T; Otsuki T; Ciceri G; Verdelli D; Lombardi L; Rocchi M; Neri A
Br J Haematol; 2004 Aug; 126(3):437-9. PubMed ID: 15257719
[No Abstract] [Full Text] [Related]
14. Plasma cell myeloma positive for t(14;20) with relapse in the central nervous system.
Murase T; Inagaki A; Masaki A; Fujii K; Narita T; Ri M; Hanamura I; Iida S; Inagaki H
J Clin Exp Hematop; 2019 Sep; 59(3):135-139. PubMed ID: 31391406
[TBL] [Abstract][Full Text] [Related]
15. Identification of primary MAFB target genes in multiple myeloma.
van Stralen E; van de Wetering M; Agnelli L; Neri A; Clevers HC; Bast BJ
Exp Hematol; 2009 Jan; 37(1):78-86. PubMed ID: 19013005
[TBL] [Abstract][Full Text] [Related]
16. Spontaneous remission in a patient with t(4;14) translocation multiple myeloma.
Puig N; Trudel S; Keats JJ; Li ZH; Braggio E; Ahmann GJ; Zeng S; Fonseca R; Kukreti V
J Clin Oncol; 2009 Nov; 27(33):e194-7. PubMed ID: 19805681
[No Abstract] [Full Text] [Related]
17. Detection and follow-up of fibroblast growth factor receptor 3 expression on bone marrow and circulating plasma cells by flow cytometry in patients with t(4;14) multiple myeloma.
Chandesris MO; Soulier J; Labaume S; Crinquette A; Repellini L; Chemin K; Malphettes M; Fieschi C; Asli B; Uzunhan Y; Fermand JP; Bories JC; Arnulf B
Br J Haematol; 2007 Feb; 136(4):609-14. PubMed ID: 17223917
[TBL] [Abstract][Full Text] [Related]
18. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).
Pruneri G; Fabris S; Baldini L; Carboni N; Zagano S; Colombi MA; Ciceri G; Lombardi L; Rocchi M; Buffa R; Maiolo AT; Neri A
Am J Pathol; 2000 May; 156(5):1505-13. PubMed ID: 10793062
[TBL] [Abstract][Full Text] [Related]
19. Chromosomal translocations t(4;14), t(11;14) and proliferation rate stratify patients with mature plasma cell myelomas into groups with different survival probabilities: a molecular epidemiologic study on tissue microarrays.
Tinguely M; Jenni B; Reineke T; Korol D; Kofler A; Rousson V; Dommann-Scherrer C; Maurer R; Moch H; Probst-Hensch NM
Am J Surg Pathol; 2007 May; 31(5):690-6. PubMed ID: 17460451
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 1p21 deletion is a novel prognostic marker in patients with multiple myeloma.
Chang H; Ning Y; Qi X; Yeung J; Xu W
Br J Haematol; 2007 Oct; 139(1):51-4. PubMed ID: 17854306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
